Irvine’s Endocare Reports Loss for 1995

Endocare Inc., which makes surgical devices for treating prostate disease, said it lost $577,000 for 1995, compared with a loss of $263,000 in 1994. Per-share amounts were not available. Revenue dropped by 50% to $1.3 million, because of a shift in the urology market from laser-based therapy to electro-vaporization devices.

The company said its results were as a division of Medstone International Inc. In January, Endocare became an independent company.